AppliedXL detects early risk signals in clinical trials and provides clear explanations, enabling life sciences professionals to make proactive decisions rather than react to issues after they arise.
Tracking vetted clinical trials, scientific publications, and company announcements, it continuously gathers, validates, information in real time, creating a comprehensive ledger of risk events.
The system identifies patterns in clinical trials, uncovers hidden relationships, and provides contextual insights into company pipelines and the competitive landscape.
AppliedXL generates real-time analysis and briefings when it identifies events that match relevance criteria set by seasoned biotech journalists.
AppliedXL delivers continuous, real-time insights, unlike traditional reports that quickly become outdated.
AppliedXL uncovers hidden signals to generate new insights, while standard platforms only summarize past data.
AppliedXL anticipates potential issues by surfacing red flags across trials, even when pharma companies don’t directly disclose program details.